Indeed, ablation of TRPV1-expressing vagal afferents reduces airway hyperreactivity associated with allergic asthma and increases survival and bacterial clearance in a model of pneumonia (Tränkner et al., 2014; Baral et al., 2018). This evidence concerns the gene TRPV1 and allergic asthma.